Agoracom: Small Cap Investment - Zenith Epigenetics - Re: How & who comes up with valuations?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

How & who comes up with valuations?

fuzzyjr

Apr 17, 2024 10:25AM

Re: How & who comes up with valuations?

fuzzyjr

Apr 17, 2024 11:21AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: How & who comes up with valuations?

in response to

Re: How & who comes up with valuations?

fuzzyjr

posted on Apr 17, 2024 01:27PM

It's hard to calculate Zenith's valuation because it generates no revenue and profits.

All it has is patents. But should any of the ZEN-3694 Phase 11 trials prove effective, then the valuations will be determined on that basis. And that's not around the corner.

IMO ... Koo

2 Recommendations

Re: How & who comes up with valuations?

fuzzyjr

Apr 17, 2024 01:36PM

Re: How & who comes up with valuations?

fuzzyjr

Apr 17, 2024 01:41PM

Re: How & who comes up with valuations?

KOO-KOO2

Apr 17, 2024 01:57PM

Re: How & who comes up with valuations?